Michael S. Jaffee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael S. Jaffee has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Breton Michael Asken
Department of Clinical and Health Psychology, University of Florida, Gainesville
2 shared publications - Molly J. Sullan
Department of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA
2 shared publications - Russell M. Bauer
University of Florida
2 shared publications - Steven DeKosky
Department of Neurology, University of Florida College of Medicine, Gainesville, FL 32610, USA
2 shared publications - Aliyah R. Snyder
Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA
1 shared publication - Allison Kraus
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA
1 shared publication
Latest Publications
- Open Access
- 25 May 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 176, 2110763
Force control deficits in rapid eye movement behavior disorder and Parkinson’s disease
- 25 May 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 176, 2110763
Open AccessForce control deficits in rapid eye movement behavior disorder and Parkinson’s disease
- 19 October 2024
- Published by Springer Nature
- p. 219-232
Sleep Cyclic Alternating Pattern (CAP) as a Neurophysiological Marker of Brain Health
- 19 October 2024
- Published by Springer Nature
- p. 219-232
Sleep Cyclic Alternating Pattern (CAP) as a Neurophysiological Marker of Brain Health
- 1 October 2020
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 77 (10) , 1209-1210
Should Neurologists Be Concerned With REM Sleep Quantity?
The association between sleep and overall health and well-being has long been of interest to physicians, researchers, and the general public. At the highest lev
- 1 October 2020
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 77 (10) , 1209-1210
Should Neurologists Be Concerned With REM Sleep Quantity?
The association between sleep and overall health and well-being has long been of interest to physicians, researchers, and the general public. At the highest lev
- 1 January 2018
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 84, 316-324
Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy
- 1 January 2018
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 84, 316-324
Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy
- 25 August 2016
- Published by Springer Nature in Neuropsychology Review
- Vol. 26 (4) , 340-363
Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review
Chronic traumatic encephalopathy (CTE) is a neuropathologically defined disease reportedly linked to a history of repetitive brain trauma. As such, retired collision sport athletes are likely at heightened risk for developing CTE. Researchers have described distinct pathological features of CTE as well a wide range of clinical symptom presentations, recently termed traumatic encephalopathy syndrome (TES). These clinical symptoms are highly variable, non-specific to individuals described as having CTE pathology in case reports, and are often associated with many other factors. This review describes the cognitive, emotional, and behavioral changes associated with 1) developmental and demographic factors, 2) neurodevelopmental disorders, 3) normal aging, 4) adjusting to retirement, 5) drug and alcohol abuse, 6) surgeries and anesthesia, and 7) sleep difficulties, as well as the relationship between these factors and risk for developing dementia-related neurodegenerative disease. We discuss why some professional athletes may be particularly susceptible to many of these effects and the importance of choosing appropriate controls groups when designing research protocols. We conclude that these factors should be considered as modifiers predominantly of the clinical outcomes associated with repetitive brain trauma within a broader biopsychosocial framework when interpreting and attributing symptom development, though also note potential effects on neuropathological outcomes. Importantly, this could have significant treatment implications for improving quality of life.
- 25 August 2016
- Published by Springer Nature in Neuropsychology Review
- Vol. 26 (4) , 340-363
Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review
Chronic traumatic encephalopathy (CTE) is a neuropathologically defined disease reportedly linked to a history of repetitive brain trauma. As such, retired collision sport athletes are likely at heightened risk for developing CTE. Researchers have described distinct pathological features of CTE as well a wide range of clinical symptom presentations, recently termed traumatic encephalopathy syndrome (TES). These clinical symptoms are highly variable, non-specific to individuals described as having CTE pathology in case reports, and are often associated with many other factors. This review describes the cognitive, emotional, and behavioral changes associated with 1) developmental and demographic factors, 2) neurodevelopmental disorders, 3) normal aging, 4) adjusting to retirement, 5) drug and alcohol abuse, 6) surgeries and anesthesia, and 7) sleep difficulties, as well as the relationship between these factors and risk for developing dementia-related neurodegenerative disease. We discuss why some professional athletes may be particularly susceptible to many of these effects and the importance of choosing appropriate controls groups when designing research protocols. We conclude that these factors should be considered as modifiers predominantly of the clinical outcomes associated with repetitive brain trauma within a broader biopsychosocial framework when interpreting and attributing symptom development, though also note potential effects on neuropathological outcomes. Importantly, this could have significant treatment implications for improving quality of life.